Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Re-treatment in Active Rheumatoid Arthritis
NCT02093026Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2002
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 16
01
Overview
Phase 2, open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Primary endpoint: American College of Rheumatology 20 Response. Started Aug 2002; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02093026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093026.